Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar Combined With Chemotherapy for Osteosarcoma
NCT01002092Phase 2Unknown
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Feb 2009
- Primary completion
- Dec 2014
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in osteosarcoma (OS), sponsored by Simcere Pharmaceutical Group. Status: unknown.
02
Drugs
endostar
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT01002092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01002092.